comparemela.com

Latest Breaking News On - Aharashtra black fungus cases - Page 1 : comparemela.com

Maha govt caps mucormycosis treatment rates for pvt hospitals

URL copied Maharashtra govt caps mucormycosis treatment rates for private hospitals The Maharashtra government on Friday capped the charges for treatment of mucormycosis patients at private hospitals in the state, where the official number of such cases has gone above 5,000. The state health department issued a notification to this effect, asking all charitable hospitals registered under the Bombay Public Trusts Act, 1950, to follow the capped charges while treating mucormycosis patients. The state government has identified 28 types of surgeries for mucormycosis or black fungus treatment, it said. For surgeries, the minimum charges are fixed around Rs 6,000 in tier three cities, and the amount can rise up to Rs one lakh, depending on the region and the complexity of the treatment, said the notification, which will remain in force till July 31.

Maharashtra: 564 patients under-treatment for mucormycosis in Pune; 27 died so far

Maharashtra may have 2,000 black fungus cases as more states report deaths: Top developments on mucormycosis

More states have started reporting cases of black fungus among Covid patients. (PTI) While Covid-19 cases and deaths continue to plague the battered health infrastructure of the country, the new fear of mucormycosis or black fungus is causing more worries. Maharashtra has reported more deaths caused by the black fungus while the government has said there may be 2,000 cases of mucormycosis in the state. On Monday, Odisha also reported its first case of mucormycosis while Delhi, Gujarat and a few other states have already detected cases of the feared black fungus. Top developments on black fungus cases: 1. On Wednesday, Thane district in Maharashtra reported 2 more deaths caused by the black fungus. Moreover, six other patients in Thane are undergoing treatment for the black fungus infection.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.